• Allergan Aesthetics, part of AbbVie, said it will present new global consumer research and updates to its AA Signature framework at AMWC 2026 in Monaco.
• The company reported surveying more than 12,000 consumers across nine countries in research conducted in November and December 2025.
• Allergan Aesthetics said 62% of respondents found multiple aesthetic treatments appealing and 78% would be more satisfied with a long-term plan agreed with a practitioner.
• At AMWC 2026, it plans to deliver two Allergan Medical Institute symposia on March 26 and March 27 focused on multimodal treatment planning and sequencing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603190300PR_NEWS_USPR_____CG12493) on March 19, 2026, and is solely responsible for the information contained therein.